http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20083269-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79a227fa56dc64adacedd461d2db1a5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-12
filingDate 2008-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5933b03fee7c8d10bd67106c23747091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2602201f9dea0c1fef38723edad45319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e509a77a1269e6ffe1118c35fa267349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689480968906c65e6295e63e273fd8af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f83451c88d5f131965a7d75a1de5671
publicationDate 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20083269-L
titleOfInvention Process for using crystalline orlistat methods
abstract A process for the preparation of crystalline forms of orlistat, in particular orlistat crystalline Form I and orlistat crystalline Form II, is disclosed.
priorityDate 2005-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034010

Total number of triples: 18.